Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its give attention to its patented prescription medicines.
Bloomberg | Bloomberg | Getty Images
The chief executive of Swiss pharmaceutical giant Novartis on Thursday warned the coronavirus pandemic will likely settle into an endemic phase and renewed calls for policymakers to sufficiently finance pandemic preparedness.
“Should you look over the past two years, we’ve got populations which have built up immunity, you might have a virus that is continuing to make shifts, but I believe what we’ll settle into is more of an endemic environment with respect to coronaviruses and the Covid virus specifically,” Vas Narasimhan, CEO of Novartis, told CNBC on the World Economic Forum in Davos, Switzerland.
“That can mean we could have sporadic outbreaks, we could have populations in danger that have to proceed to be vaccinated but I’d expect because it has been the case with other coronaviruses over the past centuries that the human populations will adapt and can come to a sort of resolution with this virus.”
Narasimhan, who has previously warned that future pandemics are certain to occur, made clear that world leaders must learn from the coronavirus crisis to be in a greater place for future pandemics.
“I believe what is actually essential now could be we turn our attention to pandemic preparedness for the long run,” Narasimhan said.
“I’m undecided we’ve got learned our lessons of the past that we want to take a position in [research and development], we want to take a position more in preparedness to be ready for the following pandemic — and I believe that must be on the worldwide agenda,” he added.
‘Straining credulity’
His comments come shortly after U.N. Secretary-General Antonio Guterres warned the world’s failure to organize for future pandemics is “straining credulity.”
Speaking at WEF on Wednesday, Guterres said, “Someway — in any case we’ve got endured — we’ve got not learned the worldwide public health lessons of the pandemic. We’re nowhere near ready for pandemics to come back.”
Last month, China abruptly ended most Covid-19 controls, resulting in a surge in infections among the many population of 1.4 billion.
Asked whether it makes pharmacological sense for some governments to take a tricky line on the entry of Chinese residents into their country following Beijing’s reopening, Narasimhan replied, “I believe from an epidemiological standpoint, you possibly can definitely call it into query because in the long run, we have learned the hard way these viruses will move regardless, and so they don’t really concentrate to national borders.”
“I proceed to imagine open borders and open economies are the suitable solution for the worldwide order,” he added.
